Jonathan Anderman is Gen Counsel & Corporate Sec of Compass Therapeutics, Inc.. Currently has a direct ownership of 21,000 shares of CMPX, which is worth approximately $36,750. The most recent transaction as insider was on Apr 07, 2025, when has been sold 20,000 shares (Common Stock) at a price of $1.54 per share, resulting in proceeds of $30,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21K
n/a 3M change
n/a 12M change
Total Value Held $36,750

Jonathan Anderman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 07 2025
BUY
Open market or private purchase
$30,800 $1.54 p/Share
20,000 Added 48.78%
21,000 Common Stock
JA

Jonathan Anderman

Gen Counsel & Corporate Sec
Boston, MA

Track Institutional and Insider Activities on CMPX

Follow Compass Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CMPX shares.

Notify only if

Insider Trading

Get notified when an Compass Therapeutics, Inc. insider buys or sells CMPX shares.

Notify only if

News

Receive news related to Compass Therapeutics, Inc.

Track Activities on CMPX